IDEA Collider: Innovation & Asymmetric Learning in Pharma
Revitalizing Pharma Collaborations: The Reblozyl Case Study
· 44 min · Season 3 Episode 8
Show notes
In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the Reblozyl project, undertaken in collaboration with Acceleron and Celgene. Rick, the head of Growth and Innovation at IDEA, reminisces about the early days leading to the successful positioning and market shaping of luspatercept across different hematological indications. The episode features insightful contributions from Robin, Jane, and Tracy, key players from Acceleron and Celgene, who share their experiences and the collaborative efforts that enabled them to redefine the market. The…
Website: ideacollider.simplecast.com
